| Product Code: ETC12838798 | Publication Date: Apr 2025 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Sachin Kumar Rai | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Canada Influenza Vaccines Market Overview |
3.1 Canada Country Macro Economic Indicators |
3.2 Canada Influenza Vaccines Market Revenues & Volume, 2021 & 2031F |
3.3 Canada Influenza Vaccines Market - Industry Life Cycle |
3.4 Canada Influenza Vaccines Market - Porter's Five Forces |
3.5 Canada Influenza Vaccines Market Revenues & Volume Share, By Vaccine Type, 2021 & 2031F |
3.6 Canada Influenza Vaccines Market Revenues & Volume Share, By Strain Type, 2021 & 2031F |
3.7 Canada Influenza Vaccines Market Revenues & Volume Share, By Age Group, 2021 & 2031F |
3.8 Canada Influenza Vaccines Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
4 Canada Influenza Vaccines Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing awareness about the importance of vaccination in preventing influenza |
4.2.2 Government initiatives to promote vaccination programs |
4.2.3 Growing elderly population in Canada |
4.3 Market Restraints |
4.3.1 Seasonal nature of influenza outbreaks |
4.3.2 Vaccine supply chain challenges |
4.3.3 Vaccine hesitancy among certain population segments |
5 Canada Influenza Vaccines Market Trends |
6 Canada Influenza Vaccines Market, By Types |
6.1 Canada Influenza Vaccines Market, By Vaccine Type |
6.1.1 Overview and Analysis |
6.1.2 Canada Influenza Vaccines Market Revenues & Volume, By Vaccine Type, 2021 - 2031F |
6.1.3 Canada Influenza Vaccines Market Revenues & Volume, By Inactivated Influenza Vaccine (IIV), 2021 - 2031F |
6.1.4 Canada Influenza Vaccines Market Revenues & Volume, By Live Attenuated Influenza Vaccine (LAIV), 2021 - 2031F |
6.1.5 Canada Influenza Vaccines Market Revenues & Volume, By Recombinant Influenza Vaccine, 2021 - 2031F |
6.2 Canada Influenza Vaccines Market, By Strain Type |
6.2.1 Overview and Analysis |
6.2.2 Canada Influenza Vaccines Market Revenues & Volume, By Trivalent Vaccines, 2021 - 2031F |
6.2.3 Canada Influenza Vaccines Market Revenues & Volume, By Quadrivalent Vaccines, 2021 - 2031F |
6.3 Canada Influenza Vaccines Market, By Age Group |
6.3.1 Overview and Analysis |
6.3.2 Canada Influenza Vaccines Market Revenues & Volume, By Pediatric, 2021 - 2031F |
6.3.3 Canada Influenza Vaccines Market Revenues & Volume, By Adult, 2021 - 2031F |
6.3.4 Canada Influenza Vaccines Market Revenues & Volume, By Geriatric, 2021 - 2031F |
6.4 Canada Influenza Vaccines Market, By Route of Administration |
6.4.1 Overview and Analysis |
6.4.2 Canada Influenza Vaccines Market Revenues & Volume, By Injectable, 2021 - 2031F |
6.4.3 Canada Influenza Vaccines Market Revenues & Volume, By Nasal Spray, 2021 - 2031F |
7 Canada Influenza Vaccines Market Import-Export Trade Statistics |
7.1 Canada Influenza Vaccines Market Export to Major Countries |
7.2 Canada Influenza Vaccines Market Imports from Major Countries |
8 Canada Influenza Vaccines Market Key Performance Indicators |
8.1 Vaccination coverage rate among high-risk populations |
8.2 Number of government-funded vaccination campaigns |
8.3 Rate of influenza-related hospitalizations and deaths |
8.4 Research and development investments in new vaccine technologies |
9 Canada Influenza Vaccines Market - Opportunity Assessment |
9.1 Canada Influenza Vaccines Market Opportunity Assessment, By Vaccine Type, 2021 & 2031F |
9.2 Canada Influenza Vaccines Market Opportunity Assessment, By Strain Type, 2021 & 2031F |
9.3 Canada Influenza Vaccines Market Opportunity Assessment, By Age Group, 2021 & 2031F |
9.4 Canada Influenza Vaccines Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
10 Canada Influenza Vaccines Market - Competitive Landscape |
10.1 Canada Influenza Vaccines Market Revenue Share, By Companies, 2024 |
10.2 Canada Influenza Vaccines Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here